These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 26864700)

  • 21. Activation of blood coagulation and thrombin generation in acute ischemic stroke treated with rtPA.
    Goldman S; Prior SM; Bembenek JP; Niewada M; Broniatowska E; Członkowska A; Butenas S; Undas A
    J Thromb Thrombolysis; 2017 Oct; 44(3):362-370. PubMed ID: 28879581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thrombolysis in acute ischemic stroke.
    Hicks P
    J Am Board Fam Pract; 1998; 11(5):422-3. PubMed ID: 9796775
    [No Abstract]   [Full Text] [Related]  

  • 23. Contemporary acute ischemic stroke therapy with intravenous recombinant tissue plasminogen activator.
    Frank JI
    Clin Neurosurg; 2000; 46():261-6. PubMed ID: 10944682
    [No Abstract]   [Full Text] [Related]  

  • 24. Recombinant tissue plasminogen activator (rt-PA) utilisation by rural clinicians in acute ischaemic stroke: an audit of current practice and clinical outcomes.
    Williams JM; Navin TJ; Jude MR; Levi CR
    Aust J Rural Health; 2013 Aug; 21(4):203-7. PubMed ID: 24033520
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
    Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
    Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness of thrombolysis with recombinant tissue plasminogen activator for acute ischemic stroke assessed by a model based on UK NHS costs.
    Sandercock P; Berge E; Dennis M; Forbes J; Hand P; Kwan J; Lewis S; Lindley R; Neilson A; Wardlaw J
    Stroke; 2004 Jun; 35(6):1490-7. PubMed ID: 15105519
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tissue-plasminogen activator for acute ischaemic stroke.
    Ellis SJ
    Lancet; 1997 Feb; 349(9050):504. PubMed ID: 9040600
    [No Abstract]   [Full Text] [Related]  

  • 28. Tissue-plasminogen activator for acute ischaemic stroke.
    Bruno A
    Lancet; 1997 Feb; 349(9050):503-4. PubMed ID: 9040599
    [No Abstract]   [Full Text] [Related]  

  • 29. Acute ischemic stroke.
    Chiti A; Giorli E; Orlandi G
    N Engl J Med; 2007 Nov; 357(21):2203; author reply 2204. PubMed ID: 18032775
    [No Abstract]   [Full Text] [Related]  

  • 30. Outcomes of Thai patients with acute ischemic stroke after intravenous thrombolysis.
    Dharmasaroja PA; Dharmasaroja P; Muengtaweepongsa S
    J Neurol Sci; 2011 Jan; 300(1-2):74-7. PubMed ID: 20937509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK.
    Walters MR; Muir KW; Harbison J; Lees KR; Ford GA
    Cerebrovasc Dis; 2005; 20(6):438-42. PubMed ID: 16230848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breaking the 3 h barrier for treatment of acute ischaemic stroke.
    Donnan GA; Davis SM
    Lancet Neurol; 2008 Nov; 7(11):981-2. PubMed ID: 18940690
    [No Abstract]   [Full Text] [Related]  

  • 33. Thrombolysis with alteplase 4.5-6 hours after acute ischemic stroke.
    Zhang B; Sun XJ; Ju CH
    Eur Neurol; 2011; 65(3):170-4. PubMed ID: 21372577
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intravenous thrombolytic therapy for acute ischemic stroke.
    Wechsler LR
    N Engl J Med; 2011 Jun; 364(22):2138-46. PubMed ID: 21631326
    [No Abstract]   [Full Text] [Related]  

  • 35. MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death.
    Inzitari D; Giusti B; Nencini P; Gori AM; Nesi M; Palumbo V; Piccardi B; Armillis A; Pracucci G; Bono G; Bovi P; Consoli D; Guidotti M; Nucera A; Massaro F; Micieli G; Orlandi G; Perini F; Tassi R; Tola MR; Sessa M; Toni D; Abbate R;
    Stroke; 2013 Oct; 44(10):2901-3. PubMed ID: 23908067
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravenous thrombolysis for patients with ischaemic stroke on antiplatelet therapy: a blessing in disguise?
    Uyttenboogaart M; Luijckx GJ
    Eur J Neurol; 2010 Feb; 17(2):177-8. PubMed ID: 19922454
    [No Abstract]   [Full Text] [Related]  

  • 38. [Treatment of acute ischemic apoplexy].
    Andersen G; Krieger DW; Iversen HK
    Ugeskr Laeger; 2009 Mar; 171(13):1094. PubMed ID: 19321089
    [No Abstract]   [Full Text] [Related]  

  • 39. Do centres with well-developed protocols, training and infrastructure have higher rates of thrombolysis for acute ischaemic stroke?
    van Wijngaarden JD; Dirks M; Niessen LW; Huijsman R; Dippel DW
    QJM; 2011 Sep; 104(9):785-91. PubMed ID: 21613273
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke.
    Amaro S; Soy D; Obach V; Cervera A; Planas AM; Chamorro A
    Stroke; 2007 Jul; 38(7):2173-5. PubMed ID: 17525395
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.